Mlinar B, Biagi B A, Enyeart J J
Department of Pharmacology, Ohio State University, College of Medicine, Columbus 43210-1239, USA.
J Biol Chem. 1995 Sep 8;270(36):20942-51. doi: 10.1074/jbc.270.36.20942.
In bovine adrenal zona fasciculata (AZF) cells, angiotensin II (AII) may stimulate depolarization-dependent Ca2+ entry and cortisol secretion through inhibition of a novel potassium channel (IAC), which appears to set the resting potential of these cells. Aspects of the signaling pathway, which couples AII receptors to membrane depolarization and secretion, were characterized in patch clamp and membrane potential recordings and in secretion studies. AII-mediated inhibition of IAC, membrane depolarization, and cortisol secretion were all blocked by the AII type I (AT1) receptor antagonist losartan. These responses were unaffected by the AT2 antagonist PD123319. Inhibition of IAC by AII was prevented by intracellular application of guanosine 5'-O-2-(thio)-diphosphate but was not affected by pre-incubation of cells with pertussis toxin. Although mediated through an AT1 receptor, several lines of evidence indicated that AII inhibition of IAC occurred through an unusual phospholipase C (PLC)-independent pathway. Acetylcholine, which activates PLC in AZF cells, did not inhibit IAC. Neither the PLC antagonist neomycin nor PLC-generated second messengers prevented IAC expression or mimicked the inhibition of this current by AII. IAC expression and inhibition by AII were insensitive to variations in intracellular or extracellular Ca2+ concentration. AII-mediated inhibition of IAC was markedly reduced by the non-hydrolyzable ATP analog adenosine 5'-(beta, gamma-imino)triphosphate and by the non-selective protein kinase inhibitor staurosporine. The protein phosphatase antagonist okadaic acid reversibly inhibited IAC in whole cell recordings. These findings indicate that AII-stimulated effects on IAC current, membrane voltage, and cortisol secretion are linked through a common AT1 receptor. Inhibition of IAC in AZF cells appears to occur through a novel signaling pathway, which may include a losartan-sensitive AT1 receptor coupled through a pertussis-insensitive G protein to a staurosporine-sensitive protein kinase. Apparently, the mechanism linking AT1 receptors to IAC inhibition and Ca2+ influx in adrenocortical cells is separate from that involving inositol trisphosphate-stimulated Ca2+ release from intracellular stores. AII-stimulated cortisol secretion may occur through distinct parallel signaling pathways.
在牛肾上腺束状带(AZF)细胞中,血管紧张素II(AII)可能通过抑制一种新型钾通道(IAC)来刺激依赖去极化的Ca2+内流和皮质醇分泌,该钾通道似乎设定了这些细胞的静息电位。在膜片钳、膜电位记录和分泌研究中,对将AII受体与膜去极化和分泌偶联的信号通路的各个方面进行了表征。AII介导的对IAC的抑制、膜去极化和皮质醇分泌均被AII 1型(AT1)受体拮抗剂氯沙坦阻断。这些反应不受AT2拮抗剂PD123319的影响。细胞内应用鸟苷5'-O-2-(硫代)-二磷酸可阻止AII对IAC的抑制,但细胞用百日咳毒素预孵育对此无影响。尽管是通过AT1受体介导的,但几条证据表明AII对IAC的抑制是通过一条不寻常的非磷脂酶C(PLC)依赖性途径发生的。乙酰胆碱可激活AZF细胞中的PLC,但不抑制IAC。PLC拮抗剂新霉素和PLC产生的第二信使均不能阻止IAC的表达,也不能模拟AII对该电流的抑制。IAC的表达和AII对其的抑制对细胞内或细胞外Ca2+浓度的变化不敏感。不可水解的ATP类似物腺苷5'-(β,γ-亚氨基)三磷酸和非选择性蛋白激酶抑制剂星形孢菌素可显著降低AII介导的对IAC的抑制。蛋白磷酸酶拮抗剂冈田酸在全细胞记录中可逆地抑制IAC。这些发现表明,AII对IAC电流、膜电压和皮质醇分泌的刺激作用是通过一个共同的AT1受体联系在一起的。AZF细胞中IAC的抑制似乎是通过一条新的信号通路发生的,该通路可能包括一个对氯沙坦敏感的AT1受体,通过一个对百日咳不敏感的G蛋白与一个对星形孢菌素敏感的蛋白激酶偶联。显然,将AT1受体与肾上腺皮质细胞中IAC抑制和Ca2+内流联系起来的机制与涉及肌醇三磷酸刺激细胞内储存释放Ca2+的机制不同。AII刺激的皮质醇分泌可能通过不同的平行信号通路发生。